Consultant Toxicology, 84503 Altötting, Germany.
Fraunhofer Institute for Process Engineering and Packaging (IVV), Giggenhauser Str. 35, 85354 Freising, Germany.
Toxicol Lett. 2024 Aug;399 Suppl 1:80-104. doi: 10.1016/j.toxlet.2023.07.016. Epub 2023 Aug 3.
Synthetic amorphous silica (SAS) is used as additive in a variety of industrial applications for many decades and has been approved to be used in food, food contact materials, pharmaceuticals, and cosmetics. Due its internal structure, SAS is considered as a nanomaterial, thus it is affected by a general safety discussion. Based on the production process, SAS for cosmetic application is a nanomaterial by the EU Recommendation, although it was not considered as such, because the solely size-dependent definitions of the term "nanomaterial" emerged in recent times first in Recommendation 2011/696/EU. Therefore, former physicochemical and toxicological evaluations of SAS were already performed on nanomaterials, however, without being addressed as such. Safety concerns can only emerge if two criteria, (toxicological) hazard and exposure towards the substance is fulfilled at the same time. In case of SAS, the Scientific Committee on Consumer Safety (SCCS) challenged provided data to be insufficient to draw a conclusion regarding the safety of SAS and thus, requested further investigations, in particular by exploring skin penetration of particulate SAS.Investigation of specific particulate substances in skin penetration tests is an analytical challenge. The number of available analytical techniques that are capable to detect nanomaterials in complex matrices, like receptor fluids from skin penetration testing, are limited and still emerging. In the new studies, a comprehensive set of analytical techniques were used to investigate the skin penetration potential of SAS. Particle-sensitive, element and particle-specific combinations of techniques and different sample preparation procedures, that respected the particulate nature of SAS, were used to detect SAS in receptor fluids directly. In addition, electron microscopic techniques were used to examine different layers of skin to detect adsorbed SAS.The combination of Asymmetric Flow Field-Flow Fractionation (AF4) in combination with Inductively Coupled Plasma Mass Spectrometry (ICP-MS) for examination of receptor fluids and Scanning Electron Microscopy coupled with Energy Dispersive X-ray spectroscopy (SEM/EDX) for examination of skin itself, were identified as suitable techniques for the detection of SAS in skin penetration tests. Data from literature was used to compare the results of the studies with the outcome of other test systems (other particles, other techniques). Both, the test results, and literature evaluation led to the conclusion, that SAS does not penetrate skin. Based on this outcome and local and systemic dermal toxicity review of SAS, it can be concluded that dermal application of SAS in cosmetic formulations is negligible.
合成无定形二氧化硅(SAS)作为添加剂被广泛应用于各种工业领域已达数十年之久,并且已被批准用于食品、食品接触材料、药品和化妆品。由于其内部结构,SAS 被认为是一种纳米材料,因此它受到了普遍的安全讨论的影响。根据生产工艺,欧盟建议将用于化妆品的 SAS 视为纳米材料,尽管它之前并未被视为纳米材料,因为“纳米材料”这一术语的唯一依赖于尺寸的定义是在最近才首次出现在 2011/696/EU 号建议中。因此,尽管之前已经对 SAS 进行了纳米材料的理化和毒理学评估,但并未将其作为纳米材料进行讨论。只有当同时满足两个标准,即(毒理学)危害和物质暴露,才会产生安全问题。对于 SAS 来说,消费者安全科学委员会(SCCS)认为现有的数据不足以得出关于 SAS 安全性的结论,因此要求进一步调查,特别是探索 SAS 的皮肤穿透性。在皮肤穿透试验中对特定颗粒物质进行研究是一个分析上的挑战。能够检测复杂基质(如皮肤穿透试验受体液)中纳米材料的现有分析技术的数量有限,且仍在不断发展。在新的研究中,使用了一整套分析技术来研究 SAS 的皮肤穿透潜力。使用了颗粒敏感、元素和颗粒特异性的技术组合以及不同的样品制备程序,以尊重 SAS 的颗粒性质,直接在受体液中检测 SAS。此外,还使用电子显微镜技术检查皮肤的不同层,以检测吸附的 SAS。不对称流场流分离(AF4)与电感耦合等离子体质谱(ICP-MS)联用检查受体液,以及扫描电子显微镜与能量色散 X 射线光谱(SEM/EDX)联用检查皮肤本身,被确定为皮肤穿透试验中检测 SAS 的合适技术。使用文献中的数据将这些研究的结果与其他测试系统(其他颗粒、其他技术)的结果进行了比较。测试结果和文献评估都得出了 SAS 不会穿透皮肤的结论。基于这一结果以及对 SAS 的局部和全身皮肤毒性的评估,可以得出结论,化妆品配方中 SAS 的经皮应用可以忽略不计。